Skip to main content
. 2024 Mar 14;19(4):875–885. doi: 10.1021/acschembio.3c00607

Figure 5.

Figure 5

Nucleolar morphological changes monitored by fibrillarin redistribution (fibrillarin: green, DAPI: gray) for ActD (5 nM), oxaliplatin (10 μM), phenanthriplatin (0.5 μM), and 13 (0.5 μM) at 24 h treatment in A549 cells (n = 3). The white arrow indicates nucleolar cap formation. Scale bar = 10 μm.